Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients

Documenti analoghi

• Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
  di: Tomas, E, et al.
  Pubblicazione: (2009)
• Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
  di: Schroeder, T, et al.
  Pubblicazione: (2005)
• Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
  di: Solé Violan, J, et al.
  Pubblicazione: (2014)
• Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
  di: Makino, S, et al.
  Pubblicazione: (2015)
• Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
  di: Filippo Mariano, et al.
  Pubblicazione: (2011-01-01)